Showing results (31-40 of 318) with videos related to

Sort By:
Pageof 32
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 14, 2011
Transient Hepatic Parenchymal Enhancement detected at dynamic imaging: a short instruction manual for the clinicianStefano Colagrande, Silvia Pradella, Silvia Lucarini, et al.
Best Practice & Research. Clinical Gastroenterology|April 19, 2011
Fibrosis in alcoholic and nonalcoholic steatohepatitisRamon Bataller, Krista Rombouts, José Altamirano, et al.
International Journal of Molecular Sciences|September 26, 2018
The Role of Stroma in Cholangiocarcinoma: The Intriguing Interplay between Fibroblastic Component, Immune Cell Subsets and Tumor EpitheliumAlessandra Gentilini, Mirella Pastore, Fabio Marra, et al.
Seminars in Liver Disease|May 18, 2019
Novel Drivers of the Inflammatory Response in Liver Injury and FibrosisAlexander Wree, Theresa Maria Holtmann, Maria Eugenia Inzaugarat, et al.
Internal and Emergency Medicine|July 10, 2021
From advanced disease to transplantation: an overview of the liver at the time of COVID-19 pandemicGiovanni Vitale, Stefano Gitto, Fabio Marra, et al.
Cancer Research|August 18, 2004
Lack of correlation between expression of HIF-1alpha protein and oxygenation status in identical tissue areas of squamous cell carcinomas of the uterine cervixArnulf Mayer, Alexander Wree, Michael Höckel, et al.
Nature Reviews. Gastroenterology & Hepatology|August 21, 2013
From NAFLD to NASH to cirrhosis-new insights into disease mechanismsAlexander Wree, Lori Broderick, Ali Canbay, et al.
Digestive Diseases (Basel, Switzerland)|September 7, 2011
Modulation of liver fibrosis by adipokinesFabio Marra, Nadia Navari, Elisa Vivoli, et al.
Annals of Hepatology|June 16, 2012
Glycogenic hepatopathy associated with type 1 diabetes mellitus as a cause of recurrent liver damageSara Messeri, Luca Messerini, Francesco Vizzutti, et al.
Internal and Emergency Medicine|July 28, 2026
GLP-1 receptor agonists at the crossroads of diabetes, hepatic steatosis, and hepatocellular carcinomaAlfredo Vozza, Filippo Biagi, Chiara Raggi, et al.
Pageof 32